Latest Articles
-
What’s New in CMS Quality Programs
The 2022 PQA Annual Meeting hosted a general session to discuss recent changes across Centers for Medicare & Medicaid (CMS) quality programs and future implications. The May 4 session, “What’s New in CMS Quality Program,” welcomed Sharon Jhawar, PharmD, MBS, Chief Pharmacy Officer of SCAN Health Plan; Chris Powers, PharmD, Vice President of Part […] -
Quality Forum Review: Impacting Patient Outcomes Through Pharmacist-Led Virtual Care Model
The PQA Quality Forum Webinar is a regular, recurring series on healthcare quality topics with a focus on medication use and medication services. It is a forum for educating and engaging with PQA members and quality-focused healthcare professionals. PQA’s July 21, 2022, Quality Forum welcomed speakers from Cureatr to discuss their pharmacist-led, patient-centered virtual care […] -
RAND Technical Expert Panel Explores Measure Concepts for Medicare Advantage and Part D VBAs
RAND convened a technical expert panel (TEP) in February 2022 to gather input about potentially developing a measure to capture value-based care arrangements (VBAs) that Medicare Advantage (MA) organizations have with contracted providers. The Centers for Medicare and Medicaid (CMS) could consider including such a measure in future MA and Part D Star Ratings. This […] -
Q&A with PQA Senior Research Scientist Megha Parikh
PQA’s talented staff is dedicated to improving medication safety, adherence and appropriate use. As experts in measure development, research, education and convening, they lead the implementation of PQA’s quality initiatives to support better medication use and high-quality care. This blog is one in a series profiling PQA’s staff. Megha Parikh is PQA’s Senior Research Scientist. […] -
Five For Friday, August 26: Celebrating Success in Advancing Medication Use Quality
PQA has begun developing a health plan performance measure for chronic obstructive pulmonary disease (COPD). COPD is a high-burden and expensive condition, so ensuring effective, high-quality treatment is a priority for patients and those who care for them. PQA is accepting nominations for a Technical Expert Panel (TEP) that will launch in October to refine the […] -
PQA Developing Health Plan Measure for COPD Treatment Ratio
PQA, the Pharmacy Quality Alliance, has begun developing a health plan performance measure for chronic obstructive pulmonary disease (COPD). Chronic lower respiratory disease, primarily COPD, is the fourth leading cause of death in the United States. Almost 15.7 million Americans have been diagnosed with COPD. The actual number is likely higher, as half of adults […] -
Plenty to Celebrate in 2022
As the summer winds down, we are quickly approaching the end of 2022. PQA has been busy this year, in collaboration with our members, advancing the quality of medication use through measure development and stewardship, education, research and convening. While several months remain in the year, we already have a lot to celebrate. The 2022 PQA Headlines […] -
Quality Essentials Review: PQA Statin Use Measures
The PQA Quality Essentials Webinar provides education on the fundamentals of quality measurement, which is important for effective measure implementation and performance, and information about where and how PQA quality measures are used. PQA’s June 16, 2022, Quality Essentials Webinar featured Rachel Digmann, PharmD, Senior Director of Performance Measurement, and Ben Shirley, CPHQ, Director of Performance Measurement, at PQA. Lisa Hines, PharmD, CPHQ, PQA’s Chief Quality […] -
Five For Friday, August 12: Celebrating Success in Advancing Medication Use Quality
We are excited to announce that we will be open registration for the 2022 PQA Leadership Summit later this month. This year’s summit will take place November 10-11 in Arlington, Va., and explore quality and value in medication use from patient, provider, purchaser, payer and industry perspectives. One individual from each PQA member organization is invited to […] -
Measure Stewardship with Expert Input and Consensus-Based Process
PQA follows a systematic, transparent and consensus-based development process to ensure that measures are important, scientifically acceptable, feasible and usable. However, the measurement lifecycle does not end when a measure is endorsed. Previous blogs have walked through the measure conceptualization, measure specification and measure testing and measure endorsement phases of the measure development lifecycle. This blog will describe the measure maintenance process, which […]
PQA In the News
-
PQA’s quality roadmap: Micah Cost on the next era of medication quality measurement
-
Focusing Quality Measures on Outcomes and Patient Experience
-
Value-Based Pharmacy Model Helps Boost Care Quality
-
PQA presents Quality Awards to 10 Medicare plan contracts for high achievement in medication quality measures
-
Pharmacy Quality Alliance Elects 2026 Board of Directors and Executive Committee
Request a PQA Expert
For members of the media or who wish to speak with an expert source on quality, please contact:
Download Media Materials
For PQA logos, images and other communications collateral, please contact:
Leading the Conversation About Medication Quality
“Quality medication use is essential to value-based, person-centered care. Through connection, collaboration, and consensus, PQA drives improvements to promote the best medication-related care and outcomes for patients.”
Micah Cost, PharmD, MS, CAE, Chief Executive Officer
Strategic Media Partnerships
PQA partners with a variety of media to provide news, insights and opinions.
Stay Informed
Get the latest PQA news and events delivered to your inbox.